Hologic Inc (HOLX)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin 50.92% 51.40% 51.65% 55.91% 58.87% 61.64% 63.35% 64.22% 65.56% 67.40% 68.86% 68.91% 65.57% 58.98% 46.89% 45.83% 34.56% 34.77% 40.49% 40.58%
Operating profit margin 15.22% 16.58% 16.76% 23.15% 28.24% 33.73% 37.10% 37.72% 40.71% 44.04% 47.22% 47.13% 41.13% 29.26% 11.70% 10.23% -4.12% -3.68% 1.86% 1.50%
Pretax margin 15.83% 16.78% 16.69% 22.44% 26.99% 32.66% 35.50% 36.06% 39.15% 41.92% 45.34% 45.10% 38.29% 26.52% 7.95% 6.25% -7.81% -7.66% -1.92% -2.22%
Net profit margin 12.98% 11.31% 11.99% 18.56% 22.17% 26.78% 28.93% 28.78% 31.23% 33.20% 35.93% 35.78% 30.38% 29.41% 14.98% 13.56% 2.47% -6.05% -0.89% -0.32%

Hologic Inc's profitability ratios have shown varying trends over the past few quarters. The gross profit margin has been gradually decreasing from 67.40% in June 2021 to 50.92% in December 2023. This could indicate a potential decrease in pricing power or increased cost of goods sold.

Similarly, the operating profit margin has also shown a declining trend, falling from 47.22% in June 2021 to 15.22% in December 2023. This significant decrease may demonstrate challenges in controlling operating expenses or generating sufficient revenues to cover costs.

The pretax margin has followed a similar pattern, declining from 45.34% in June 2021 to 15.83% in December 2023. This suggests that the company's profitability before taxes has been impacted by various factors, such as increased expenses or lower revenues.

The net profit margin has also decreased over the periods, from 35.93% in June 2021 to 12.98% in December 2023. This declining trend in net profitability indicates that the company's bottom-line earnings have been under pressure, possibly due to a combination of factors affecting both revenues and expenses.

Overall, the declining trend in profitability ratios for Hologic Inc raises concerns about its ability to sustain profitability levels in the future and may warrant a closer examination of its cost structure, revenue generation, and overall financial performance management.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) 7.13% 7.31% 7.25% 9.94% 13.58% 18.08% 20.72% 21.37% 24.08% 27.81% 31.12% 31.15% 24.71% 15.36% 5.67% 4.98% -2.21% -1.92% 0.94% 0.76%
Return on assets (ROA) 6.08% 4.99% 5.18% 7.97% 10.66% 14.35% 16.16% 16.31% 18.48% 20.96% 23.68% 23.65% 18.25% 15.43% 7.25% 6.61% 1.32% -3.16% -0.45% -0.16%
Return on total capital 10.27% 10.43% 9.80% 12.50% 16.49% 21.90% 24.95% 26.78% 30.55% 35.42% 40.78% 38.66% 31.03% 20.63% 7.79% 7.07% -2.53% -2.39% 1.53% 1.35%
Return on equity (ROE) 11.07% 9.09% 9.34% 14.21% 19.44% 26.70% 30.25% 32.38% 37.96% 44.32% 52.47% 50.14% 42.17% 41.05% 21.88% 21.62% 3.71% -9.62% -1.34% -0.49%

Hologic Inc's profitability ratios have fluctuated over the past several quarters.

1. Operating return on assets (Operating ROA) has shown a decreasing trend from 31.15% in March 2021 to 7.13% in December 2023. This indicates that the company's operating profit generated from its assets has been declining over time.

2. Return on assets (ROA) has also exhibited a downward trajectory, falling from 23.65% in March 2021 to 6.08% in December 2023. This suggests that the overall profitability of the company in relation to its total assets has decreased.

3. Return on total capital has followed a similar pattern, declining from 38.66% in December 2021 to 10.27% in December 2023. This ratio reflects the firm's ability to generate profits from both equity and debt capital employed.

4. Return on equity (ROE) has also experienced a downward trend, dropping from 52.47% in June 2021 to 11.07% in December 2023. ROE measures the profitability of the company for its shareholders, and the decline indicates a decrease in the return earned on shareholder equity.

Overall, the declining profitability ratios suggest that Hologic Inc may be facing challenges in efficiently utilizing its assets and capital to generate profits, which may warrant further investigation into the company's operational efficiency and financial performance.